{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:09 23:24:50.411",
            "Expression": "mesenchymal Provacel",
            "NStudiesAvail": 430269,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "PrimaryOutcomeTimeFrame",
                  "ReferenceCitation",
                  "ReferencePMID",
                  "ReferenceType",
                  "RemovedCountry",
                  "ResponsiblePartyInvestigatorAffiliation",
                  "ResponsiblePartyInvestigatorFullName",
                  "ResponsiblePartyInvestigatorTitle",
                  "ResponsiblePartyOldNameTitle",
                  "ResponsiblePartyOldOrganization",
                  "ResponsiblePartyType",
                  "ResultsFirstPostDate",
                  "ResultsFirstPostDateType",
                  "ResultsFirstPostedQCCommentsDate",
                  "ResultsFirstPostedQCCommentsDateType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "PrimaryOutcomeTimeFrame": [
                              "6 months"
                        ],
                        "ReferenceCitation": [
                              "Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res. 2002 Dec 13;91(12):1092-102. Review.",
                              "Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004 Jul 9;95(1):9-20. Review.",
                              "Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002 Jun;73(6):1919-25; discussion 1926.",
                              "Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009 Dec 8;54(24):2277-86. doi: 10.1016/j.jacc.2009.06.055."
                        ],
                        "ReferencePMID": [
                              "12480809",
                              "15242981",
                              "12078791",
                              "19958962"
                        ],
                        "ReferenceType": [
                              "background",
                              "background",
                              "background",
                              "derived"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT00114452"
                        ]
                  }
            ]
      }
}